Change of Nominated Adviser
TheraCryf plc has appointed Strand Hanson Limited as its new Financial and Nominated Adviser, effective immediately, while Turner Pope Investments will continue to serve as the Company’s sole broker. This change in advisory services is the primary announcement from the company.
Select text to share a quote on X · sign in to keep highlights & notes in your TCF notes
TheraCryf plc, the biotech company developing new medicines for addiction and other neuropsychiatric disorders, announces that it has appointed Strand Hanson Limited as its Financial and Nominated Adviser with immediate effect.
Turner Pope Investments remains the Company’s sole broker.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.